Skip to main content
Premium Trial:

Request an Annual Quote

CLC Bio, RainDance Partner on Tailored Software

NEW YORK (GenomeWeb News) – RainDance Technologies and CLC Bio will partner to develop software for analyzing targeted resequence data developed using RainDance's microdroplet technology, CLC Bio said today.

The software solution the companies develop will be interoperable with major next-generation sequencing systems, including ABI's SoLiD, Illumina's Genome Analyzer, and Roche/454 sequencers.

CLC Bio said that it first plans to expand its Genomics Workbench to enhance data analysis speed and efficacy when used with the RainDance RainStorm technology. The Danish firm said that in the future the partners plan to release specialized reports, data analyses, and workflow support for targeted resequencing research.

"Having decided to focus on high-throughput sequencing technologies several years ago, we're constantly monitoring the market to identify new and complimentary technologies being developed," CLB Bio CEO Thomas Knudsen said in a statement.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more